Kynurenine Pathway Enzymes in Different Species of Animals

  • Graziella Allegri
  • Antonella Bertazzo
  • Monica Biasiolo
  • Carlo V. L. Costa
  • Eugenio Ragazzi
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 527)


Kynurenine pathway enzyme activities, liver tryptophan 2,3-dioxygenase (TDO), small intestine indole 2,3-dioxygenase (IDO), liver and kidney kynurenine. 3monooxygenase, kynurenine-oxoglutarate transaminase, kynureninase, 3-hydroxyanthranilate 3,4-dioxygenase and aminocarboxymuconate-semialdehyde decarboxylase, were assayed in rabbits, rats, mice and guinea pigs. Their activities varied among species. Especially, TDO was present as both holoenzyme and apoenzyme only in rat, while the other species, rabbit, mouse and guinea pig, only showed holoenzyme activity. Mitochondrial liver and kidney kynurenine 3-monooxygenase activities were much higher in mouse and rat, with rabbit showing the lowest activity. Kynureninase activity showed similar values in both liver and kidney in each species. However, lower activity was present in rabbit. As regards kynurenine-oxoglutarate transaminase, the highest activity appeared in kidney, in all species studied. 3-Hydroxyanthranilate 3,4dioxygenase activity showed different behaviour in the four species. In rabbit, its activity was higher in kidney than in liver; in rat and mouse, it was viceversa; and in guinea pig, both liver and kidney had similar activity. Instead, the activity of aminocarboxymuconate-semialdehyde decarboxylase was higher in kidney than in liver only in guinea pig. Serum tryptophan concentrations were also determined. Rabbit and guinea pig showed similar values, whereas in rat and mouse, serum tryptophan levels were higher, rat having the highest concentrations. In all species assayed, the free fraction was present as 11-12% of total tryptophan.


Quinolinic Acid Kynurenic Acid Kynurenine Pathway Picolinic Acid Tryptophan Metabolism 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    L. Musajo and C.A. Benassi, Aspects of disorders of the kynurenine pathway of tryptophan metabolism in manAdv. Clin. Chem. 763–135 (1964).PubMedCrossRefGoogle Scholar
  2. 2.
    F.M., Chiancone, Enzymes of the tryptophan nicotinic acid pathway, in:Newer methods of nutritional biochemistryedited by A.A. Albanese, Vol. 2 (Academic Press, New York, 1965), pp. 249–284.Google Scholar
  3. 3.
    J.M. Price, R.R Brown, N. Yess, Testing the functional capacity of the tryptophan-niacin pathway in man by analysis of urinary metabolitesAdv. Metab. Disorders2, 159–225 (1965).Google Scholar
  4. 4.
    H. Wolf, Studies on tryptophan metabolism in manScand. J. Clin. Lab. Invest. Suppl.136, 1–186 (1974).PubMedGoogle Scholar
  5. 5.
    J.C. Peters, Tryptophan nutrition and metabolism: an overview, in:Kynurenine and Serotonin Pathwaysedited by R. Schwarcz et al. (Plenum Press, New York, 1991), pp. 345–358.CrossRefGoogle Scholar
  6. 6.
    R.R. Brown, Tryptophan metabolism: a review, in:L-Tryptophan Current Prospects in Medicine and Drug Safetyedited by W. Kochen and H. Steinhart (de Gruyter, Berlin-Hauthorne, 1994), pp.17–30.Google Scholar
  7. 7.
    F. Yamakazi, T. Kuroiwa, O. Takikawa and R.Kido, Human indolylamine 2,3-dioxygenase. Its tissue distribution and characterization of the placental enzymeBiochem. J.230, 635–638 (1985).Google Scholar
  8. 8.
    E. Okuno and R.Kido, Kynureninase and kynurenine 3-hydroxylase in mammalian tissues, in:Kynurenine and Serotonin Pathwaysedited by R.Schwarcz et al.. (Plenum Press, New York, 1991), pp. 167–176.CrossRefGoogle Scholar
  9. 9.
    G. Allegri, C.A. Benassi, E. Boccù, A. De Nadai, and B. Perissinotto, Tryptophan-pyrrolase, kynureninase and kynurenine transaminase activities of human renal tumorsBrit. J. Cancer19, 754–760 (1965).PubMedCrossRefGoogle Scholar
  10. 10.
    A. Bertazzo, C.V.L. Costa, M.Lise, D.Nitti and G.Allegti, Occurence of indoleamine 2,3-dioxygenase in human cutaneous malignant melanomaAdv.Exp. Merl. Biol.398, 519–522 (1996).CrossRefGoogle Scholar
  11. 11.
    G. Allegri, C. Costa, A. De Antoni, F. Baccichetti, S. Vanzan, Effect of psoralen-induced. photodermatitis on tryptophan metabolism in guinea pigsII Farmaco Ed. Sci.36, 557–564 (1981).Google Scholar
  12. 12.
    A. A-B. Badawy and M. Evans, Guinea-pig liver tryptophan pyrrolase. Absence of detectable apoenzyme activity and of hormonal induction by cortisol and possible regulation by tryptophanBiochem. J.138, 445–451 (1974).PubMedGoogle Scholar
  13. 13.
    A. A-B. Badawy and M. Evans, Animal liver tryptophan pyrrolases. Absence of apoenzyme and of hormonal induction mechanism from species sensitive to tryptophan toxicityBiochem. J.158, 79–88 (1976).PubMedGoogle Scholar
  14. 14.
    J. Hvitefelt and R.S. Santti, Tryptophan pyrrolase in the liver of guinea pig: The absence of hydrocortisone inductionBiochim. Biophys. Acta258, 358–365 (1972).PubMedCrossRefGoogle Scholar
  15. 15.
    J.N. Brown and C.L. Dodgen, Fish liver tryptophan pyrrolase: The apparent absence of both hormonal and substrate inductionBiochim. Biophys. Acta165, 463–469 (1968).CrossRefGoogle Scholar
  16. 16.
    R.J. Johnson and L.A. Dyer, Effect of orally administered tryptophan on tryptophan pyrrolase activity in ovine and bovineLife Sci.5, 1121–1124 (1966).PubMedCrossRefGoogle Scholar
  17. 17.
    M. Spiegel, Tryptophan pyrrolase activity in the liver of adult rana pipiensBiol. Bull.121, 547–553 (1961).CrossRefGoogle Scholar
  18. 18.
    K.L. Baughman and J.M. Franz, Control of tryptophan oxygenase and formamidase activity in the gerbilInt. J. Biochem.2, 201–211 (1971).CrossRefGoogle Scholar
  19. 19.
    J.E. Leklem, J. Woodford and R.R. Brown, Comparative tryptophan metabolism in cats and ratsComp. Biochem. Physiol.31, 95–109 (1969).PubMedCrossRefGoogle Scholar
  20. 20.
    E. Ragazzi, C.L.V. Costa, L. Caparrotta, M. Biasiolo, A. Bertazzo, G. Allegri, Enzyme activities along the tryptophan-nicotinic acid pathway in alloxan diabetic rabbits.Biochim. Biophys. Acta1571, 9–17 (2002).PubMedCrossRefGoogle Scholar
  21. 21.
    O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall, Protein measurement with the Folin phenol reagentJ. Biol. Chem.193, 265–275 (1951).PubMedGoogle Scholar
  22. 22.
    G. Allegri, C. Costa, A. De Antoni, F. Baccichetti, S. Vanzan, F.F. Rubaltelli, Effect of exposure to light on enzyme activities and tryptophan metabolites of the kynurenine pathway in Wistar, in heterozygous and homozygous adult and newborn Gunn ratsPhotochem Photobiol.35, 691–696 (1982).PubMedCrossRefGoogle Scholar
  23. 23.
    C. Costa, A. De Antoni, F. Baccichetti, S. Vanzan, M. Appodia, G. Allegri, Strain differences in the tryptophan metabolite excretion and enzyme activities along the kynurenine pathway in rats, It.J. Biochem.31, 412–418 (1982).Google Scholar
  24. 24.
    A. De Antoni, C. Costa, F. Baccichetti, E.L. Cardin de’ Stefani, S. Vanzan, G. Allegri, Enzyme activities and metabolites along the kynurenine pathway in mice with Harding-Passey melanomaActa Vitaminol Enzymol.5:83–87 (1983).PubMedGoogle Scholar
  25. 25.
    C. Costa, A. De Antoni, F. Baccichetti, M. Biasiolo, G. Allegri, Metabolites and enzyme activities involved in tryptophan metabolism in two different strains of mouseIt. J. Biochem.33, 319–324 (1984).Google Scholar

Copyright information

© Springer Science+Business Media New York 2003

Authors and Affiliations

  • Graziella Allegri
    • 1
  • Antonella Bertazzo
    • 1
  • Monica Biasiolo
    • 1
  • Carlo V. L. Costa
    • 1
  • Eugenio Ragazzi
    • 2
  1. 1.Department of Pharmaceutical SciencesUniversity of PadovaPadovaItaly
  2. 2.Department of Pharmacology and AnaesthesiologyLargo Meneghetti 2PadovaItaly

Personalised recommendations